No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
VTAK Catheter Precision
- 2.667
- -0.033-1.23%
Close Jul 22 16:00 ET
- 2.640
- -0.027-1.01%
Post 19:35 ET
2.40MMarket Cap0.02P/E (TTM)
2.740High2.500Low22.92KVolume2.628Open2.700Pre Close60.19KTurnover3.12%Turnover RatioLossP/E (Static)901.25KShares8.40052wk High0.13P/B1.96MFloat Cap2.50052wk Low--Dividend TTM734.38KShs Float275000.000Historical High--Div YieldTTM8.89%Amplitude2.500Historical Low2.625Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Catheter Precision, Inc. Announces the Completion of Patient Follow-up for the VIVO European Registry and New Product Evaluations of VIVO
FORT MILL, SC / ACCESSWIRE / July 16, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based innovative medical device company, announced today that the patient follow-up phase for the
Express News | Catheter Precision Shares Are Trading Lower After the Company Announced a 1-for-10 Reverse Stock Split
Express News | Amex Halt Add Info Lst 3.050000
Catheter Precision, Inc. Announces Effectiveness of 1-for-10 Reverse Stock Split
FORT MILLS, SC / ACCESSWIRE / July 15, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based innovative medical device company, announced today that its previously announced 1-for-10
Catheter Precision To Carry Out 1-for-10 Reverse Stock Split On July 15th, 2024
July 12th (Eastern Time) - $Catheter Precision(VTAK.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from July 15th, 2024.$
Catheter Precision Shareholders Approve Key Corporate Changes
Comments
$Catheter Precision(VTAK.US$ Catheter Precision, Inc. Announces the Completion of Patient Follow-up for the VIVO European Registry and New Product Evaluations of VIVO
Accesswire· 2 mins ago
Accesswire· 2 mins ago
2
$Catheter Precision(VTAK.US$ Catheter Precision, Inc. (NYSE American: VTAK) Reports Preliminary Unaudited Revenue for the Second Quarter and Six Months Ended June 30, 2024 15% Quarter Over Quarter Growth – Initial Sales of LockeT Recorded Fort Mill, SC, July 1, 2024 – Catheter Precision, Inc. (NYSE/American: VTAK) a MedTech company pioneering products in the growing field of cardiac electrophysiology, including its VIVO™ and LockeT product(s), releases Q2 R...
$Catheter Precision(VTAK.US$
Catheter Precision Inc - Intends to Effect a Reverse Stock Split of Its Common Stock at a Ratio of 1 Post-Split Share for Every 10 Pre-Split Shares - July 15,2024
Catheter Precision Inc - Intends to Effect a Reverse Stock Split of Its Common Stock at a Ratio of 1 Post-Split Share for Every 10 Pre-Split Shares - July 15,2024
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg